Sociologist William Julius Wilson to speak for Assembly Series

William Julius Wilson, the Lewis P. and Linda L. Geyser University Professor at Harvard University, will present this year’s Chancellor’s Fellows Lecture, “Race and Affirmative Opportunity in the Barack Obama Era” at 11 a.m. Tuesday, March 27, in Graham Chapel for the Assembly Series. His talk is free and open to the public.

$4.2 million grant helps plan, launch first Alzheimer’s prevention trials

Washington University School of Medicine in St. Louis has received nearly $4.2 million from the Alzheimer’s Association to accelerate the launch of the first clinical trials to prevent Alzheimer’s disease before symptoms become apparent. John C. Morris, MD, the Harvey A. and Dorismae Hacker Friedman Professor of Neurology, heads the Dominantly Inherited Alzheimer’s Network at the School of Medicine.

Drug makes leukemia more vulnerable to chemo

A new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells, according to John F. DiPersio, MD, PhD, and his colleagues at Washington University. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.

Symposium to feature postdoc research

Postdoctoral researchers will showcase their work at the 8th Annual Postdoc Scientific Symposium at Washington University School of Medicine in St. Louis. The symposium will be held from 11:30 a.m.-5:30 p.m., March 29, 2012, at the Farrell Learning and Teaching Center Atrium and Connor Auditorium.

Louis Sullivan to lead health-care forum

Louis W. Sullivan, MD, secretary of the Department of Health and Human Services in the administration of President George H. W. Bush and president emeritus of the Morehouse School of Medicine, will lead a public forum on the future of health care at 4 p.m. Wednesday, April 11, at the Eric P. Newman Education Center, 320 S. Euclid Ave., at Washington University School of Medicine in St. Louis.

Scientists map genetic evolution of leukemia

By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, Matthew Walter and their Washington University colleagues have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop early in the disease.

Researchers identify unexpected player in intestinal immunity

With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass. Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn’t mount an attack. Their discovery provides scientists with a potential target for therapies against inflammatory bowel disease, celiac disease and food allergies.
View More Stories